ASPM and prostate carcinoma: Recent work has identified that ASPM interacts with disheveled-3 (Dvl-3), a cardinal upstream regulator of canonical Wnt signaling, and inhibits its proteasome-dependent degradation, thereby increasing its protein stability and enabling β-catenin transcriptional activity in prostate cancer cells [11].